Annals of Hepatology
Издатель: Elsevier · ISSN 1665-2681 · 100 статей
- Can liver biopsy be spared for the diagnosis of autoimmune hepatitis in selected children? A multicenter retrospective study
- Optimal screening criteria for metabolic dysfunction-associated steatotic liver disease with fibrosis
- Association of nonselective β blockers with the development of hepatocellular carcinoma in liver cirrhosis: a meta-analysis
- Plasma exchange for acute and acute-on-chronic liver failure: A systematic review and patient-level survival data meta-analysis
- Serum EV Lipidomics identifies candidate markers associated with MASLD-related HCC
- Nationwide analysis on the impact of the organization of care on the outcomes of perihilar cholangiocarcinoma
- Relationship between sleep patterns and incident liver related events: retrospective analysis of prospectively collected data from UK Biobank participants
- The association of frailty with cardiovascular diseases and mortality in metabolic dysfunction-associated steatotic liver disease
- Simple model stratifies liver cancer risk in non-cirrhotic chronic hepatitis C patients after viral eradication
- Screening and management for portal hypertension in hepatocellular carcinoma: A nationwide survey in China
- The role of inpatient palliative care consultation in end-stage liver disease: Too little, too late?
- Patient-Centred Sleep Outcome Definitions in Primary Biliary Cholangitis: A Call for Patient Engagement in Future Research
- International expert Delphi consensus on the management of metabolic dysfunction- and alcohol-associated liver disease (MetALD)
- Interpreting large esophageal varices as a predictor of hepatocellular carcinoma
- First-day clinical phenotyping in acute-on-chronic liver failure: a 24-hour landmark analysis with preliminary external reproducibility
- Development and validation of the HABIT score: a practical and robust tool to predict hepatic steatosis using HbA1c, BMI, and triglycerides in patients with unexplained elevated liver enzymes
- Development and validation of a prediction model for acute kidney injury in cirrhosis with normal serum creatinine levels
- Trends of metabolic dysfunction-associated steatotic liver disease in Mexico, 1990–2023: insights from the Global Burden of disease study
- Role of spot urine analyses in patients with cirrhosis and ascites as the single first decompensation event
- The impact of early allograft dysfunction severity on graft and recipient outcomes in pediatric liver transplantation
- Predictors of recompensation in immunosuppressive therapy for biopsy-proven autoimmune hepatitis patients with decompensated cirrhosis
- MRI imaging and machine learning based radiomics for detection of mixed HCC and CCA tumors
- PAI-1 as a modulator of the EMT-associated signaling pathway during HCV protein expression
- Longitudinal health-related quality of life and associated factors in autoimmune liver diseases
- A prospective cohort validation study of a multivariable algorithm ASAP for risk stratification of hepatocellular carcinoma surveillance
- The absence of the alpha-7 nicotinic acetylcholine receptor impairs liver regeneration due to altered autophagic response after resection
- Association between antihypertensive medications and hepatocellular carcinoma risk in individuals with metabolic dysfunction–associated steatotic liver disease (MASLD) without cirrhosis
- Challenges and adherence to hepatocellular carcinoma surveillance in patients with advanced chronic liver disease
- Asia-Pacific perspectives on the steatotic liver disease (SLD) reclassification: balancing terminology, diagnostic criteria, and implementation
- Stem cell therapies for liver cirrhosis: a GRADE evaluation through a systematic review